These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18762328)

  • 1. The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines.
    Chapman MD; Ferreira F; Villalba M; Cromwell O; Bryan D; Becker WM; Fernández-Rivas M; Durham S; Vieths S; van Ree R;
    J Allergy Clin Immunol; 2008 Nov; 122(5):882-889.e2. PubMed ID: 18762328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reactivity of candidate reference materials.
    Fernandez-Rivas M; Aalbers M; Fötisch K; de Heer P; Notten S; Vieths S; van Ree R
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):84-8; discussion 88-90, 100-4. PubMed ID: 17393727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification.
    van Ree R; Chapman MD; Ferreira F; Vieths S; Bryan D; Cromwell O; Villalba M; Durham SR; Becker WM; Aalbers M; André C; Barber D; Cistero Bahima A; Custovic A; Didierlaurent A; Dolman C; Dorpema JW; Di Felice G; Eberhardt F; Fernandez Caldas E; Fernandez Rivas M; Fiebig H; Focke M; Fötisch K; Gadermaier G; Das RG; Gonzalez Mancebo E; Himly M; Kinaciyan T; Knulst AC; Kroon AM; Lepp U; Marco FM; Mari A; Moingeon P; Monsalve R; Neubauer A; Notten S; Ooievaar-de Heer P; Pauli G; Pini C; Purohit A; Quiralte J; Rak S; Raulf-Heimsoth M; San Miguel Moncin MM; Simpson B; Tsay A; Vailes L; Wallner M; Weber B
    Allergy; 2008 Mar; 63(3):310-26. PubMed ID: 18269676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a low immunoglobulin E-binding mutant of the timothy grass pollen major allergen Phl p 5a.
    Wald M; Kahlert H; Weber B; Jankovic M; Keller W; Cromwell O; Nandy A; Fiebig H
    Clin Exp Allergy; 2007 Mar; 37(3):441-50. PubMed ID: 17359394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of IgE reactivity profiles among European mite allergic patients.
    Weghofer M; Thomas WR; Kronqvist M; Mari A; Purohit A; Pauli G; Horak F; Grönlund H; van Hage M; Valenta R; Vrtala S
    Eur J Clin Invest; 2008 Dec; 38(12):959-65. PubMed ID: 19021722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
    Weghofer M; Grote M; Dall'Antonia Y; Fernández-Caldas E; Krauth MT; van Hage M; Horak F; Thomas WR; Valent P; Keller W; Valenta R; Vrtala S
    Int Arch Allergy Immunol; 2008; 147(2):101-9. PubMed ID: 18520154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome.
    Marcucci F; Sensi L; Di Cara G; Gidaro G; Incorvaia C; Frati F
    Int J Immunopathol Pharmacol; 2006; 19(1):141-8. PubMed ID: 16569352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut.
    Lauer I; Dueringer N; Pokoj S; Rehm S; Zoccatelli G; Reese G; Miguel-Moncin MS; Cistero-Bahima A; Enrique E; Lidholm J; Vieths S; Scheurer S
    Clin Exp Allergy; 2009 Sep; 39(9):1427-37. PubMed ID: 19624524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-arrayed wheat seed and grass pollen allergens for component-resolved diagnosis.
    Constantin C; Quirce S; Poorafshar M; Touraev A; Niggemann B; Mari A; Ebner C; Akerström H; Heberle-Bors E; Nystrand M; Valenta R
    Allergy; 2009 Jul; 64(7):1030-7. PubMed ID: 19210348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediator release assays based on human or murine immunoglobulin E in allergen standardization.
    Kaul S; Lüttkopf D; Kastner B; Vogel L; Höltz G; Vieths S; Hoffmann A
    Clin Exp Allergy; 2007 Jan; 37(1):141-50. PubMed ID: 17210052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergy vaccines: a need for standardisation in mass units of major allergen.
    van Ree R; Dorpema JW; Vieths S
    Pharmeuropa Bio; 2005 Sep; 2005(1):27-30. PubMed ID: 16336936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.
    Himly M; Nandy A; Kahlert H; Thilker M; Steiner M; Briza P; Neubauer A; Klysner S; van Ree R; Buchheit KH; Vieths S; Ferreira F
    Allergy; 2016 Apr; 71(4):495-504. PubMed ID: 26687027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant lipid transfer protein Tri a 14: a novel heat and proteolytic resistant tool for the diagnosis of baker's asthma.
    Palacin A; Varela J; Quirce S; del Pozo V; Tordesillas L; Barranco P; Fernandez-Nieto M; Sastre J; Diaz-Perales A; Salcedo G
    Clin Exp Allergy; 2009 Aug; 39(8):1267-76. PubMed ID: 19486028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CREATE project: EU support for the improvement of allergen standardization in Europe.
    van Ree R;
    Allergy; 2004 Jun; 59(6):571-4. PubMed ID: 15147439
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of recombinant Mal d 4 and its application for component-resolved diagnosis of apple allergy.
    Ma Y; Zuidmeer L; Bohle B; Bolhaar ST; Gadermaier G; Gonzalez-Mancebo E; Fernandez-Rivas M; Knulst AC; Himly M; Asero R; Ebner C; van Ree R; Ferreira F; Breiteneder H; Hoffmann-Sommergruber K
    Clin Exp Allergy; 2006 Aug; 36(8):1087-96. PubMed ID: 16911365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation.
    Himly M; Nony E; Chabre H; Van Overtvelt L; Neubauer A; van Ree R; Buchheit KH; Vieths S; Moingeon P; Ferreira F
    Allergy; 2009 Jul; 64(7):1038-45. PubMed ID: 19183416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.